ATXI
AVENUE THERAPEUTICS, INC.
Key Financials
Revenue
$1.4M
↑ Infinity%
Operating Income
$-3083000
↑ 72.7%
Net Income
$-2909000
↑ 75.0%
EPS (Diluted)
$-0.22
↑ 29.0%
Total Assets
$2.9M
↑ 9.7%
Cash & Equivalents
$2.9M
↑ 10.1%
Total Liabilities
$1.1M
↑ 34.7%
Shareholders' Equity
$1.8M
↓ 34.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ATXI |
| Company Name | AVENUE THERAPEUTICS, INC. |
| CIK | 1644963 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 781-652-4500 |